Logo

SINOMED(R) Concludes Enrollment of the PIONEER III Randomized,...

TIANJIN, China, July 23, 2019 /PRNewswire-AsiaNet/ -- North America, Europe and Japan trial seeks approval for the US and Japanese marketsIn a significant milestone toward obtaining key regulatory approvals for the BuMA Supreme Drug-Eluting Stent (DES) System, SINOMED has completed enrollment in ...

Authors: LATEST ASIANET NEWS RELEASES

Read more

Asian Spectator by NewsServices.com - office@NewsServices.com - 1300 660 660